Medaltus, LLC – Trademark Portfolio
Entity Type: 16
Medaltus, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include ASKDERM, MEDALTUS, PURISTICS, and TOTALLY AGELESS. The owner is based in Ladson, SC.
265 Treeland Dr., Ste. A
Ladson, SC 29456
Showing of trademarks Trademarks
Trademark Classifications
Medaltus, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Medaltus, LLC have?
Medaltus, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 cancelled.
What trademark classes does Medaltus, LLC file in?
Medaltus, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage). Class 35 covers advertising; business management; business administration; office functions.
What are Medaltus, LLC's most well-known trademarks?
Medaltus, LLC's registered trademark portfolio includes well-known marks such as ASKDERM, MEDALTUS, PURISTICS, and TOTALLY AGELESS. These are among 4 currently registered trademarks in the portfolio.
What is Medaltus, LLC's trademark registration success rate?
Medaltus, LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.